nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—GUCY1A3—seminal vesicle—testicular cancer	0.0255	0.0878	CbGeAlD
Nitroglycerin—GUCY1B3—seminal vesicle—testicular cancer	0.0253	0.0871	CbGeAlD
Nitroglycerin—NPR1—seminal vesicle—testicular cancer	0.0236	0.0815	CbGeAlD
Nitroglycerin—ALDH2—seminal vesicle—testicular cancer	0.0215	0.074	CbGeAlD
Nitroglycerin—GUCY1A2—testis—testicular cancer	0.021	0.0726	CbGeAlD
Nitroglycerin—ALDH2—gonad—testicular cancer	0.0155	0.0535	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—testicular cancer	0.0153	0.0526	CbGeAlD
Nitroglycerin—GUCY1A3—female gonad—testicular cancer	0.0149	0.0515	CbGeAlD
Nitroglycerin—GUCY1B3—female gonad—testicular cancer	0.0148	0.0512	CbGeAlD
Nitroglycerin—NPR1—female gonad—testicular cancer	0.0139	0.0479	CbGeAlD
Nitroglycerin—GUCY1A3—testis—testicular cancer	0.0133	0.0457	CbGeAlD
Nitroglycerin—GUCY1B3—testis—testicular cancer	0.0132	0.0454	CbGeAlD
Nitroglycerin—ALDH2—female gonad—testicular cancer	0.0126	0.0434	CbGeAlD
Nitroglycerin—NPR1—testis—testicular cancer	0.0123	0.0425	CbGeAlD
Nitroglycerin—ALDH2—testis—testicular cancer	0.0112	0.0385	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—testicular cancer	0.00961	0.0331	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—testicular cancer	0.00954	0.0329	CbGeAlD
Nitroglycerin—NPR1—lymph node—testicular cancer	0.00892	0.0308	CbGeAlD
Nitroglycerin—ALDH2—lymph node—testicular cancer	0.0081	0.0279	CbGeAlD
Nitroglycerin—Hyperhidrosis—Ifosfamide—testicular cancer	0.00183	0.00258	CcSEcCtD
Nitroglycerin—Feeling abnormal—Bleomycin—testicular cancer	0.00182	0.00257	CcSEcCtD
Nitroglycerin—Hot flush—Epirubicin—testicular cancer	0.00182	0.00257	CcSEcCtD
Nitroglycerin—Vomiting—Chlorambucil—testicular cancer	0.00182	0.00256	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00181	0.00254	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Epirubicin—testicular cancer	0.00181	0.00254	CcSEcCtD
Nitroglycerin—Hypotension—Ifosfamide—testicular cancer	0.00177	0.00249	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00176	0.00248	CcSEcCtD
Nitroglycerin—Urticaria—Bleomycin—testicular cancer	0.00176	0.00248	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—testicular cancer	0.00176	0.00247	CcSEcCtD
Nitroglycerin—Body temperature increased—Bleomycin—testicular cancer	0.00175	0.00247	CcSEcCtD
Nitroglycerin—Dizziness—Vinblastine—testicular cancer	0.00173	0.00244	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—testicular cancer	0.00171	0.00241	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dactinomycin—testicular cancer	0.0017	0.0024	CcSEcCtD
Nitroglycerin—Nausea—Chlorambucil—testicular cancer	0.0017	0.00239	CcSEcCtD
Nitroglycerin—Paraesthesia—Ifosfamide—testicular cancer	0.0017	0.00239	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00169	0.00238	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00169	0.00238	CcSEcCtD
Nitroglycerin—Dyspnoea—Ifosfamide—testicular cancer	0.00169	0.00238	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—testicular cancer	0.00169	0.00237	CcSEcCtD
Nitroglycerin—Somnolence—Ifosfamide—testicular cancer	0.00168	0.00237	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00167	0.00235	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—testicular cancer	0.00167	0.00235	CcSEcCtD
Nitroglycerin—Vomiting—Vinblastine—testicular cancer	0.00167	0.00235	CcSEcCtD
Nitroglycerin—Vertigo—Etoposide—testicular cancer	0.00165	0.00232	CcSEcCtD
Nitroglycerin—Headache—Vinblastine—testicular cancer	0.00164	0.00231	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Abdominal pain—Dactinomycin—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Body temperature increased—Dactinomycin—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Cisplatin—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Hypersensitivity—Bleomycin—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00163	0.0023	CcSEcCtD
Nitroglycerin—Infection—Cisplatin—testicular cancer	0.00162	0.00228	CcSEcCtD
Nitroglycerin—Loss of consciousness—Etoposide—testicular cancer	0.00161	0.00227	CcSEcCtD
Nitroglycerin—Nervous system disorder—Cisplatin—testicular cancer	0.0016	0.00225	CcSEcCtD
Nitroglycerin—Tachycardia—Cisplatin—testicular cancer	0.00159	0.00224	CcSEcCtD
Nitroglycerin—Asthenia—Bleomycin—testicular cancer	0.00159	0.00224	CcSEcCtD
Nitroglycerin—Skin disorder—Cisplatin—testicular cancer	0.00158	0.00223	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Cisplatin—testicular cancer	0.00158	0.00222	CcSEcCtD
Nitroglycerin—Pruritus—Bleomycin—testicular cancer	0.00157	0.00221	CcSEcCtD
Nitroglycerin—Feeling abnormal—Ifosfamide—testicular cancer	0.00156	0.0022	CcSEcCtD
Nitroglycerin—Nausea—Vinblastine—testicular cancer	0.00156	0.00219	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—testicular cancer	0.00156	0.00219	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00155	0.00218	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00155	0.00218	CcSEcCtD
Nitroglycerin—Hypotension—Cisplatin—testicular cancer	0.00152	0.00215	CcSEcCtD
Nitroglycerin—Hypersensitivity—Dactinomycin—testicular cancer	0.00152	0.00214	CcSEcCtD
Nitroglycerin—Confusional state—Etoposide—testicular cancer	0.00151	0.00212	CcSEcCtD
Nitroglycerin—Urticaria—Ifosfamide—testicular cancer	0.0015	0.00212	CcSEcCtD
Nitroglycerin—Body temperature increased—Ifosfamide—testicular cancer	0.0015	0.00211	CcSEcCtD
Nitroglycerin—Abdominal pain—Ifosfamide—testicular cancer	0.0015	0.00211	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Etoposide—testicular cancer	0.00149	0.0021	CcSEcCtD
Nitroglycerin—Infection—Etoposide—testicular cancer	0.00148	0.00209	CcSEcCtD
Nitroglycerin—Asthenia—Dactinomycin—testicular cancer	0.00148	0.00209	CcSEcCtD
Nitroglycerin—Paraesthesia—Cisplatin—testicular cancer	0.00146	0.00206	CcSEcCtD
Nitroglycerin—Tachycardia—Etoposide—testicular cancer	0.00146	0.00205	CcSEcCtD
Nitroglycerin—Dyspnoea—Cisplatin—testicular cancer	0.00145	0.00205	CcSEcCtD
Nitroglycerin—Skin disorder—Etoposide—testicular cancer	0.00145	0.00204	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Etoposide—testicular cancer	0.00144	0.00203	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00144	0.00203	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—testicular cancer	0.00144	0.00202	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00141	0.00198	CcSEcCtD
Nitroglycerin—Vomiting—Bleomycin—testicular cancer	0.00141	0.00198	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—testicular cancer	0.0014	0.00198	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—testicular cancer	0.0014	0.00198	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—testicular cancer	0.0014	0.00198	CcSEcCtD
Nitroglycerin—Hypotension—Etoposide—testicular cancer	0.0014	0.00197	CcSEcCtD
Nitroglycerin—Rash—Bleomycin—testicular cancer	0.0014	0.00197	CcSEcCtD
Nitroglycerin—Dermatitis—Bleomycin—testicular cancer	0.00139	0.00196	CcSEcCtD
Nitroglycerin—Hypersensitivity—Ifosfamide—testicular cancer	0.00139	0.00196	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—testicular cancer	0.00137	0.00193	CcSEcCtD
Nitroglycerin—Asthenia—Ifosfamide—testicular cancer	0.00136	0.00191	CcSEcCtD
Nitroglycerin—Sweating—Methotrexate—testicular cancer	0.00135	0.0019	CcSEcCtD
Nitroglycerin—Feeling abnormal—Cisplatin—testicular cancer	0.00134	0.00189	CcSEcCtD
Nitroglycerin—Paraesthesia—Etoposide—testicular cancer	0.00134	0.00189	CcSEcCtD
Nitroglycerin—Pruritus—Ifosfamide—testicular cancer	0.00134	0.00189	CcSEcCtD
Nitroglycerin—Dyspnoea—Etoposide—testicular cancer	0.00133	0.00188	CcSEcCtD
Nitroglycerin—Somnolence—Etoposide—testicular cancer	0.00133	0.00187	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—testicular cancer	0.00133	0.00187	CcSEcCtD
Nitroglycerin—Nausea—Bleomycin—testicular cancer	0.00132	0.00185	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—testicular cancer	0.00131	0.00185	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—testicular cancer	0.00131	0.00185	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—testicular cancer	0.00131	0.00185	CcSEcCtD
Nitroglycerin—Vomiting—Dactinomycin—testicular cancer	0.00131	0.00185	CcSEcCtD
Nitroglycerin—Rash—Dactinomycin—testicular cancer	0.0013	0.00183	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00129	0.00182	CcSEcCtD
Nitroglycerin—Body temperature increased—Cisplatin—testicular cancer	0.00129	0.00182	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—testicular cancer	0.00128	0.0018	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—testicular cancer	0.00126	0.00177	CcSEcCtD
Nitroglycerin—Dizziness—Ifosfamide—testicular cancer	0.00125	0.00176	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—testicular cancer	0.00125	0.00176	CcSEcCtD
Nitroglycerin—Feeling abnormal—Etoposide—testicular cancer	0.00123	0.00173	CcSEcCtD
Nitroglycerin—Nausea—Dactinomycin—testicular cancer	0.00123	0.00173	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Etoposide—testicular cancer	0.00122	0.00172	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—testicular cancer	0.00122	0.00171	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—testicular cancer	0.00122	0.00171	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—testicular cancer	0.00122	0.00171	CcSEcCtD
Nitroglycerin—Visual impairment—Methotrexate—testicular cancer	0.00121	0.00171	CcSEcCtD
Nitroglycerin—Vomiting—Ifosfamide—testicular cancer	0.0012	0.00169	CcSEcCtD
Nitroglycerin—Hypersensitivity—Cisplatin—testicular cancer	0.0012	0.00169	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—testicular cancer	0.0012	0.00169	CcSEcCtD
Nitroglycerin—Rash—Ifosfamide—testicular cancer	0.00119	0.00168	CcSEcCtD
Nitroglycerin—Dermatitis—Ifosfamide—testicular cancer	0.00119	0.00168	CcSEcCtD
Nitroglycerin—Urticaria—Etoposide—testicular cancer	0.00119	0.00167	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—testicular cancer	0.00118	0.00167	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—testicular cancer	0.00118	0.00166	CcSEcCtD
Nitroglycerin—Abdominal pain—Etoposide—testicular cancer	0.00118	0.00166	CcSEcCtD
Nitroglycerin—Body temperature increased—Etoposide—testicular cancer	0.00118	0.00166	CcSEcCtD
Nitroglycerin—Asthenia—Cisplatin—testicular cancer	0.00117	0.00165	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—testicular cancer	0.00117	0.00165	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—testicular cancer	0.00117	0.00165	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—testicular cancer	0.00117	0.00164	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—testicular cancer	0.00116	0.00164	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—testicular cancer	0.00114	0.00161	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—testicular cancer	0.00114	0.0016	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—testicular cancer	0.00114	0.0016	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—testicular cancer	0.00114	0.0016	CcSEcCtD
Nitroglycerin—Nausea—Ifosfamide—testicular cancer	0.00112	0.00158	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—testicular cancer	0.00111	0.00156	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—testicular cancer	0.0011	0.00155	CcSEcCtD
Nitroglycerin—Hypersensitivity—Etoposide—testicular cancer	0.0011	0.00155	CcSEcCtD
Nitroglycerin—Erythema—Methotrexate—testicular cancer	0.0011	0.00154	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—testicular cancer	0.00109	0.00154	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—testicular cancer	0.00109	0.00154	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—testicular cancer	0.00109	0.00154	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—testicular cancer	0.00108	0.00153	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—testicular cancer	0.00107	0.00151	CcSEcCtD
Nitroglycerin—Asthenia—Etoposide—testicular cancer	0.00107	0.00151	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—testicular cancer	0.00107	0.00151	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—testicular cancer	0.00107	0.0015	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—testicular cancer	0.00106	0.0015	CcSEcCtD
Nitroglycerin—Pruritus—Etoposide—testicular cancer	0.00106	0.00149	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—testicular cancer	0.00105	0.00148	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—testicular cancer	0.00105	0.00148	CcSEcCtD
Nitroglycerin—Vomiting—Cisplatin—testicular cancer	0.00104	0.00146	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—testicular cancer	0.00103	0.00146	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—testicular cancer	0.00103	0.00145	CcSEcCtD
Nitroglycerin—Rash—Cisplatin—testicular cancer	0.00103	0.00145	CcSEcCtD
Nitroglycerin—Dermatitis—Cisplatin—testicular cancer	0.00103	0.00145	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—testicular cancer	0.00103	0.00145	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—testicular cancer	0.00101	0.00143	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—testicular cancer	0.00101	0.00143	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—testicular cancer	0.00099	0.00139	CcSEcCtD
Nitroglycerin—Dizziness—Etoposide—testicular cancer	0.000988	0.00139	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—testicular cancer	0.000986	0.00139	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—testicular cancer	0.000986	0.00139	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000983	0.00138	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—testicular cancer	0.000975	0.00137	CcSEcCtD
Nitroglycerin—Nausea—Cisplatin—testicular cancer	0.000969	0.00136	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—testicular cancer	0.000967	0.00136	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—testicular cancer	0.000956	0.00135	CcSEcCtD
Nitroglycerin—Vomiting—Etoposide—testicular cancer	0.00095	0.00134	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—testicular cancer	0.00095	0.00134	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—testicular cancer	0.000943	0.00133	CcSEcCtD
Nitroglycerin—Rash—Etoposide—testicular cancer	0.000942	0.00133	CcSEcCtD
Nitroglycerin—Dermatitis—Etoposide—testicular cancer	0.000942	0.00133	CcSEcCtD
Nitroglycerin—Headache—Etoposide—testicular cancer	0.000936	0.00132	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000927	0.00131	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—testicular cancer	0.000922	0.0013	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—testicular cancer	0.000921	0.0013	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—testicular cancer	0.000907	0.00128	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—testicular cancer	0.000903	0.00127	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—testicular cancer	0.000902	0.00127	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—testicular cancer	0.000895	0.00126	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—testicular cancer	0.000895	0.00126	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—testicular cancer	0.000889	0.00125	CcSEcCtD
Nitroglycerin—Nausea—Etoposide—testicular cancer	0.000888	0.00125	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methotrexate—testicular cancer	0.000878	0.00124	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—testicular cancer	0.000873	0.00123	CcSEcCtD
Nitroglycerin—Skin disorder—Methotrexate—testicular cancer	0.00087	0.00122	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000868	0.00122	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—testicular cancer	0.000865	0.00122	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—testicular cancer	0.000853	0.0012	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—testicular cancer	0.000852	0.0012	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—testicular cancer	0.000845	0.00119	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—testicular cancer	0.000839	0.00118	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—testicular cancer	0.000838	0.00118	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—testicular cancer	0.000837	0.00118	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—testicular cancer	0.000835	0.00118	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—testicular cancer	0.000832	0.00117	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—testicular cancer	0.000824	0.00116	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—testicular cancer	0.000822	0.00116	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—testicular cancer	0.000818	0.00115	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—testicular cancer	0.000814	0.00115	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—testicular cancer	0.00081	0.00114	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—testicular cancer	0.000804	0.00113	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000803	0.00113	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—testicular cancer	0.000798	0.00112	CcSEcCtD
Nitroglycerin—Somnolence—Methotrexate—testicular cancer	0.000796	0.00112	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—testicular cancer	0.000783	0.0011	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—testicular cancer	0.000782	0.0011	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000775	0.00109	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000773	0.00109	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—testicular cancer	0.00077	0.00108	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—testicular cancer	0.000763	0.00107	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—testicular cancer	0.00076	0.00107	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—testicular cancer	0.000757	0.00107	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—testicular cancer	0.000753	0.00106	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—testicular cancer	0.000752	0.00106	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000749	0.00106	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—testicular cancer	0.000747	0.00105	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—testicular cancer	0.000745	0.00105	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—testicular cancer	0.000738	0.00104	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000732	0.00103	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—testicular cancer	0.000724	0.00102	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000723	0.00102	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—testicular cancer	0.000711	0.001	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—testicular cancer	0.000708	0.000997	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—testicular cancer	0.000708	0.000997	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—testicular cancer	0.000696	0.00098	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—testicular cancer	0.000691	0.000973	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—testicular cancer	0.00069	0.000972	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—testicular cancer	0.000689	0.000971	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000685	0.000965	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000669	0.000943	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—testicular cancer	0.000666	0.000937	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—testicular cancer	0.000662	0.000933	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—testicular cancer	0.000662	0.000933	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methotrexate—testicular cancer	0.00066	0.000929	CcSEcCtD
Nitroglycerin—Asthenia—Methotrexate—testicular cancer	0.000642	0.000905	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—testicular cancer	0.000639	0.0009	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000634	0.000893	CcSEcCtD
Nitroglycerin—Pruritus—Methotrexate—testicular cancer	0.000633	0.000892	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—testicular cancer	0.000617	0.000869	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—testicular cancer	0.000616	0.000867	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—testicular cancer	0.000613	0.000863	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—testicular cancer	0.000613	0.000863	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—testicular cancer	0.000601	0.000847	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—testicular cancer	0.000593	0.000835	CcSEcCtD
Nitroglycerin—Dizziness—Methotrexate—testicular cancer	0.000592	0.000834	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—testicular cancer	0.000571	0.000804	CcSEcCtD
Nitroglycerin—Vomiting—Methotrexate—testicular cancer	0.000569	0.000802	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—testicular cancer	0.000564	0.000795	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—testicular cancer	0.000564	0.000794	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—testicular cancer	0.000561	0.00079	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—testicular cancer	0.000556	0.000783	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—testicular cancer	0.000554	0.00078	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—testicular cancer	0.000548	0.000772	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—testicular cancer	0.000533	0.00075	CcSEcCtD
Nitroglycerin—Nausea—Methotrexate—testicular cancer	0.000532	0.000749	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—testicular cancer	0.000528	0.000744	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—testicular cancer	0.000528	0.000743	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—testicular cancer	0.000525	0.000739	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—testicular cancer	0.000513	0.000722	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—testicular cancer	0.000498	0.000701	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—testicular cancer	0.000493	0.000694	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—testicular cancer	0.000489	0.000688	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—testicular cancer	0.000488	0.000688	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—testicular cancer	0.000486	0.000684	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—testicular cancer	0.00046	0.000648	CcSEcCtD
